Regina Barragan-Carrillo/X
Jun 10, 2025, 12:10
Regina Barragan-Carrillo: Adjuvant Nivolumab in MIUC – Real-World Data with a Focus on Disparities
Regina Barragan-Carrillo, Postdoctoral fellow at City of Hope, posted on X:
“Adjuvant Nivolumab in MIUC – Real-World Data with a Focus on Disparities led by Alex Chehrazi-Raffle.
A quick tweetorial:
- Can real-world outcomes of adjuvant nivolumab match those from clinical trials? And how does it perform in underrepresented groups?
- We evaluated 253 patients with muscle-invasive urothelial carcinoma (MIUC) in community settings across the US.”
Title: Clinical Outcomes in Patients With Muscle-Invasive Urothelial Carcinoma Treated With Nivolumab
Authors: Regina Barragán-Carrillo, Hedyeh Ebrahimi, William S. John, Sarah Lucht, Taavy A. Miller, Prathamesh Pathak, Emily Bland, Sarah Gordon, JaLyna Laney, Andrew J. Klink, Bruce Feinberg, Nisha Singh, Carmelo Alonso, Miraj Y. Patel, Lisa Rosenblatt, Xin Yin, Alexander Chehrazi-Raffle
Read The Full Article at JAMA Network Open.
More posts featuring Regina Barragan-Carrillo.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 4, 2025, 01:11
Jul 3, 2025, 17:51
Jul 3, 2025, 17:10